EUVIMEDEUVIMED entdecken
Open Access

Field-effect-informed urine liquid biopsy for bladder cancer

William Y Shi, Kevin J Liu, Mohammad S Esfahani, Kathleen E Mach, Nick A Phillips, Diego Almanza, Ravi K Bajpai, Joseph G Schroers-Martin, Ludimila Trabanino, Timothy J Lee, Vinh La, Gabriela Rodriguez und 24 weitere

Cell · 2026-02 · 189 (4) · 1024-1038.e9

DOI: 10.1016/j.cell.2025.12.054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2026-02. Verfasst von William Y Shi und 35 weiteren Autor:innen. Beteiligte Einrichtung: Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Department of Radiation Oncology, Stanford University, Stanford, CA, USA; Program …. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, Tobacco-Related Disease Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Only some non-muscle-invasive bladder cancer (NMIBC) patients benefit from intravesical Bacillus Calmette-Guérin (BCG), and predictive biomarkers remain lacking. While urine tumor DNA (utDNA) analysis is promising, mutations in tumor-adjacent normal urothelium, namely the field effect, limit specificity. Here, we show that the prevalence of somatic mutations in the urine increases with age. We introduce an improved utDNA minimal residual disease (MRD) approach that increases specificity by removing field-effect mutations. Applying this field-effect-informed MRD approach to 261 samples from NMIBC patients undergoing surgery and adjuvant BCG, we identify three molecular response classes, including surgical responders, BCG responders, and non-responders. Molecular predictors of response to the two treatments differ, with pre-existing immune activation and higher mutation burden enriched in BCG but not surgery responders. These findings highlight the potential of field-effect-informed liquid biopsy methods for guiding personalized therapy and uncovering biomarkers for individual components of multimodal treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsHumansLiquid BiopsyFemaleNon-Muscle Invasive Bladder NeoplasmsMutationBiomarkers, TumorMaleAgedMiddle AgedNeoplasm, ResidualBCG VaccineDNA, NeoplasmAged, 80 and over

Stichwörter der Autor:innen

bladder cancercancer biomarkerscell-free DNAfield effectimmunotherapyliquid biopsytherapy responseurine biomarker

Substanzen

Biomarkers, TumorBCG VaccineDNA, Neoplasm

Autor:innen und Institutionen

  • Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Department of Radiation Oncology, Stanford University, Stanford, CA, USA; Program in Cancer Biology, Stanford University, Stanford, CA, USA.
  • Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
  • Department of Urology, Stanford University, Stanford, CA, USA; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
  • Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Program in Cancer Biology, Stanford University, Stanford, CA, USA; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA, US…
  • Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
  • Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA, USA; Division of Oncology, Department of Medicine, Stanford Universit…

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • Tobacco-Related Disease Research Program
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Shi, W. Y., Liu, K. J., Esfahani, M. S., Mach, K. E., Phillips, N. A., Almanza, D., Bajpai, R. K., Schroers-Martin, J. G., Trabanino, L., Lee, T. J., La, V., Rodriguez, G., Holton, G., Chen, S. B., Mullane, P., Wu, D. J., Nesselbush, M. C., Sugio, T., Cheng, J. C., …, & Diehn, M. (2026). Field-effect-informed urine liquid biopsy for bladder cancer. Cell, 189(4), 1024-1038.e9. https://doi.org/10.1016/j.cell.2025.12.054

Vancouver

Shi WY, Liu KJ, Esfahani MS, Mach KE, Phillips NA, Almanza D, et al. Field-effect-informed urine liquid biopsy for bladder cancer. Cell. 2026;189(4):1024-1038.e9. doi:10.1016/j.cell.2025.12.054

BibTeX
@article{Shi2026,
  author = {Shi, William Y and Liu, Kevin J and Esfahani, Mohammad S and Mach, Kathleen E and Phillips, Nick A and Almanza, Diego and Bajpai, Ravi K and Schroers-Martin, Joseph G and Trabanino, Ludimila and Lee, Timothy J and La, Vinh and Rodriguez, Gabriela and Holton, Grace and Chen, Simon B and Mullane, Patrick and Wu, Douglas J and Nesselbush, Monica C and Sugio, Takeshi and Cheng, Jordan C and Jabara, Isabel and Hamilton, Emily G and Alig, Stefan K and Liu, Chih-Long and Peterson, Dylan J and Prado, Kris and Shkolyar, Eugene and Thong, Alan and Shah, Jay B and Gill, Harcharan and Kunder, Christian A and Chan, Emily and Khaki, Ali Raza and Skinner, Eila C and Alizadeh, Ash A and Liao, Joseph C and Diehn, Maximilian},
  title = {Field-effect-informed urine liquid biopsy for bladder cancer},
  journal = {Cell},
  year = {2026},
  volume = {189},
  number = {4},
  pages = {1024--1038.e9},
  doi = {10.1016/j.cell.2025.12.054}
}
Kostenlos starten →